Glenmark Life Sciences Limited IPO [INITIAL PUBLIC OFFERING] Detail
About the Glenmark Life Sciences Limited
The company was incorporated as ‘Zorg Laboratories Private Limited’, a private limited company under the Companies Act, 1956 on June 23, 2011 at Pune and was granted the certificate of incorporation by the Registrar of Companies, Maharashtra at Pune (“RoC”). Subsequently, the Company was acquired by Glenmark Pharmaceuticals Limited pursuant to the Share Purchase Agreement dated July 4, 2018 and the name of the Company was changed to ‘Glenmark Life Sciences Private Limited’ pursuant to a special resolution passed by the shareholders of the Company on July 25, 2018 and a fresh certificate of incorporation dated August 10, 2018 was issued by the RoC. A shareholders’ resolution was passed on August 13, 2018 to convert the Company from a private limited company to a public limited company and a fresh certificate of incorporation dated August 28, 2018 was issued by the RoC.
Registered Office: Plot No. 170-172, Chandramouli Industrial Estate, Mohol Bazarpeth, Solapur 413 213, Maharashtra, India;
Corporate Office: 4th Floor, OIA House, 470, Cardinal Gracious Road, Andheri East, Mumbai – 400099, Maharashtra, India; Tel: +91 2189 234456/ +91 2189 234246 ;
Website: www.glenmarklifesciences.com;
Contact Person: Rudalf Corriea (Company Secretary and Compliance Officer);
Company Financials
Summary of Restated Consolidated Financial Information
For the year/period ended (in ₹ million)
| Particulars | |||
|---|---|---|---|
| 31-Mar-21 | 31-Mar-20 | 31-Mar-19 | |
| Total Revenue | 18,859.76 | 15,493.03 | 8,868.65 |
| Profit After Tax | 3,515.81 | 3,130.98 | 1,955.92 |
| Total Asset | 19,970.75 | 17,256.04 | 14,753.95 |
Glenmark Life Sciences Limited – IPO Details
IPO Details
| Issue Open Date | 27 July 2021 |
| Issue Close Date | 29 July 2021 |
| Issue Type | Book Built Issue |
| Face Value | ₹ 2 per equity share |
| IPO/Issue Price | ₹ 695 to ₹ 720 per equity share |
| Market Lot | 20 Shares |
| Min Order Quantity | 20 Shares |
| Listing At | BSE, NSE |
IPO/ Issue Time Line [Tentative]
Issue Open Date
Issue Close Date
Basis of Allotment Date
Initiation of Refunds
Credit of Shares to Demat Account
IPO Listing Date
Objects of the Issue
The Company proposes to utilize the Net Proceeds from the Offer towards funding the following objects:
1. Payment of outstanding purchase consideration to the Promoter for the spin-off of the API business from the Promoter into our Company pursuant to the Business Purchase Agreement dated October 9, 2018;
- Funding capital expenditure requirements; and
- General corporate purposes
IPO FAQs
When the Glenmark Life Sciences Limited IPO will Open?
When the Glenmark Life Sciences IPO will close?
What is the lot size of Glenmark Life Sciences IPO?
Also, read other articles @ EduTaxTuber
